00

Shandong Xinhua Pharmaceutical Co Ltd

000756 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

12.19CNY-0.28 (-2.25%)

Price History

Full chart

Market Stats

Previous Close12.47
Open12.48
Day Range12.17 – 12.50
52-Week Range11.58 – 18.49
Volume8.84M
Market Cap10.17B
P/E (TTM)47.10
Forward P/E28.90
EPS0.31
Dividend Yield1.07%
Beta-0.03
50-Day Avg13.67
200-Day Avg14.52

About

Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. It offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for active pharmaceutical ingredients and pharmaceutical intermediates, OTC, and generics. The company also provides ibuprofen bulk pharmaceutical products; and prepared Chinese herbal medicine for decoction, traditional Chinese medicine, chemical bulk drugs, chemical preparations, chemical raw materials, antibiotics, biochemical medicines, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc. In addition, it offers raw materials and intermediates; internet data services, internet sales, and internet information services for pharmaceuticals and medical devices; veterinary drugs and fodders; bulk pharmaceutical and intermediates; steroid system apis and intermediates; and chemical raw materials. Further, the company produces and sells chemical products; exports and imports goods and technologies; and designs medical projects. Additionally, it engages in the property management, nonresidential real estate and housing leasing activities; certification and import and export business; installation and testing of chemical equipment; and manufacture of mechanical and electrical equipment, nonstandard equipment, as well as production and hardware and electrical equipment, and electrical installations equipment and manufacture; and sale of controller switching equipment. The company was founded in 1943 and is based in Zibo, the People's Republic of China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Tongqing He
  • Employees7.01K
  • HeadquartersNo. 1 Lutai Avenue, Zibo, China, 255086, China
  • Websitehttps://www.xhzy.com

Leadership

  • Mr. Tongqing HeExecutive Chairman · b. 1970
  • Mr. Wenhui XuGM & Executive Director · b. 1977
  • Mr. Ning HouCFO & Executive Director · b. 1974
  • Mr. Changsheng WeiDeputy GM & Manager of the Administrative Personnel Department · b. 1971
  • Mr. Xuesong LiuDeputy General Manager · b. 1985
  • Mr. Zuxing KouDeputy General Manager · b. 1982
  • Mr. Changqiu CaoCompany Secretary · b. 1970
  • Mr. Xiaohong HeHead of Accounting Department

Financials

Income Statement

Currency: CNY1994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue533.67M711.90M842.20M915.63M973.88M950.66M1.04B1.10B1.17B1.33B1.52B1.71B1.67B1.89B2.08B2.32B2.61B2.94B2.97B3.39B3.59B3.60B4.01B4.52B5.24B5.61B6.01B6.56B7.50B8.10B8.47B8.74B
Growth (%)-+33.40%+18.30%+8.72%+6.36%-2.38%+9.83%+5.29%+6.76%+13.20%+14.75%+12.31%-2.62%+13.18%+10.11%+11.75%+12.59%+12.37%+1.16%+14.12%+5.85%+0.20%+11.62%+12.47%+16.14%+6.89%+7.13%+9.23%+14.37%+7.97%+4.51%+3.26%
Cost of Revenue391.78M586.75M635.85M709.22M724.99M677.22M735.00M766.75M858.63M1.03B1.27B1.39B1.37B1.60B1.80B1.88B2.13B2.39B2.46B2.80B2.86B2.77B3.04B3.27B3.71B3.82B4.24B4.82B5.51B5.78B6.48B7.11B
Gross Profit141.89M125.14M206.36M206.41M248.90M273.44M309.07M332.51M314.92M300.86M244.64M301.65M295.90M284.56M292.75M444.50M480.54M545.95M516.36M593.55M732.56M824.12M975.82M1.25B1.53B1.79B1.76B1.74B1.99B2.32B1.99B1.63B
Gross Margin26.59%17.58%24.50%22.54%25.56%28.76%29.60%30.25%26.83%22.65%16.05%17.62%17.75%15.08%14.09%19.14%18.38%18.59%17.38%17.50%20.41%22.91%24.30%27.59%29.27%31.92%29.33%26.46%26.50%28.66%23.45%18.67%
Operating Expense77.62M85.17M107.11M107.62M178.82M196.47M221.97M230.87M229.06M248.84M273.93M276.31M268.47M280.38M233.68M297.31M331.48M474.02M480.51M540.76M678.00M732.06M823.41M964.42M1.19B1.40B1.34B1.31B1.51B1.79B1.45B1.29B
Operating Income64.27M39.97M99.24M98.79M70.08M76.97M87.10M101.64M85.86M52.02M-29.28M25.34M27.43M4.18M59.07M147.19M149.06M71.93M35.86M52.79M54.56M92.07M152.42M281.68M344.57M387.44M422.49M425.59M476.71M534.58M534.37M346.34M
Operating Margin12.04%5.61%11.78%10.79%7.20%8.10%8.34%9.25%7.32%3.92%-1.92%1.48%1.65%0.22%2.84%6.34%5.70%2.45%1.21%1.56%1.52%2.56%3.80%6.24%6.57%6.91%7.03%6.49%6.35%6.60%6.31%3.96%
EBITDA72.53M59.34M128.73M112.89M76.50M145.32M158.99M172.68M168.72M144.60M53.91M132.86M152.52M161.22M173.31M261.03M270.34M253.78M194.88M243.42M323.99M382.62M447.00M582.92M667.23M734.07M842.97M840.20M952.48M1.03B1.05B346.34M
EBITDA Margin13.59%8.34%15.29%12.33%7.85%15.29%15.23%15.71%14.38%10.88%3.54%7.76%9.15%8.54%8.34%11.24%10.34%8.64%6.56%7.18%9.03%10.64%11.13%12.91%12.72%13.09%14.04%12.81%12.69%12.67%12.40%3.96%
Net Income55.63M36.85M88.39M84.47M52.78M63.61M69.12M80.90M68.76M42.08M-55.61M5.42M22.71M32.72M30.06M102.24M97.26M76.02M23.66M39.15M50.73M83.06M122.27M209.59M255.31M299.97M324.86M348.55M411.06M496.51M470.02M289.89M
Net Income Margin10.42%5.18%10.49%9.22%5.42%6.69%6.62%7.36%5.86%3.17%-3.65%0.32%1.36%1.73%1.45%4.40%3.72%2.59%0.80%1.15%1.41%2.31%3.05%4.64%4.87%5.35%5.41%5.31%5.48%6.13%5.55%3.32%
R&D----------9.61M19.68M16.98M14.37M---34.49M30.11M49.32M84.83M117.85M110.31M161.17M186.98M235.40M298.35M341.37M345.66M419.24M413.18M381.62M
R&D as % of Total Revenue----------0.63%1.15%1.02%0.76%---1.17%1.01%1.45%2.36%3.28%2.75%3.57%3.57%4.20%4.97%5.20%4.61%5.18%4.88%4.37%
Interest Expense9.99M20.83M33.92M14.23M7.71M8.56M9.05M18.07M13.80M14.02M15.38M22.17M20.48M12.18M17.96M19.31M19.16M28.10M56.92M68.58M78.91M90.85M75.40M63.72M59.20M60.29M64.90M57.50M53.01M44.07M42.36M42.43M
Interest Expense % of Total Revenue1.87%2.93%4.03%1.55%0.79%0.90%0.87%1.64%1.18%1.06%1.01%1.29%1.23%0.65%0.86%0.83%0.73%0.96%1.92%2.02%2.20%2.53%1.88%1.41%1.13%1.08%1.08%0.88%0.71%0.54%0.50%0.49%

Balance Sheet

Currency: CNY1994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets806.15M838.95M1.21B1.22B1.30B1.38B1.36B1.84B1.91B2.09B2.30B2.21B1.88B2.27B2.16B2.63B2.74B3.00B3.63B3.85B4.25B4.49B4.72B5.27B5.92B6.44B7.09B7.33B8.27B8.29B9.02B9.19B
Total Liabilities428.34M463.49M500.90M411.52M450.68M493.33M436.81M495.93M523.11M668.11M955.56M862.47M533.37M553.96M674.74M956.22M1.03B1.25B1.85B2.05B2.33B2.51B2.64B2.69B3.12B3.33B3.70B3.68B3.92B3.51B3.80B3.73B
Total Equity377.80M375.46M711.26M805.84M849.91M890.78M925.70M1.34B1.38B1.41B1.34B1.34B1.34B1.67B1.45B1.63B1.68B1.71B1.74B1.76B1.82B1.88B1.99B2.48B2.69B2.97B3.22B3.47B4.13B4.55B4.99B5.21B
Cash19.45M8.44M306.45M228.24M51.28K289.65M279.23M617.03M503.47M413.99M337.93M363.19M162.54M212.26M238.12M401.89M404.05M299.23M422.14M380.72M328.77M476.29M561.33M731.13M778.42M690.47M855.77M744.66M1.16B918.33M1.25B1.40B
Total Debt217.35M271.16M375.65M259.84M309.13M339.38M259.10M332.10M340.00M374.16M556.29M418.97M235.23M206.82M284.47M394.02M475.53M688.47M1.21B1.36B1.47B1.49B1.35B1.17B1.36B1.48B1.09B1.04B1.38B1.87B1.35B1.31B
Net Debt197.90M262.72M69.20M31.60M309.08M49.73M-20.13M-284.93M-163.47M-39.83M218.35M55.78M72.70M-5.44M46.35M-7.87M71.48M389.24M788.87M983.71M1.15B1.02B793.52M441.83M585.86M789.16M231.77M299.09M225.11M955.82M107.78M-84.16M

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow71.15M50.64M167.54M-13.72M42.71M131.32M59.12M178.86M133.30M120.59M103.48K344.80M173.00M97.08M37.82M92.64M346.34M348.64M439.35M389.97M344.61M348.27M420.19M259.12M758.24M265.28M367.61M533.73M
Investing Cash Flow-60.97M-66.45M-79.64M-71.10M-143.86M-237.81M-299.20M-1.69M-87.44M40.85M-163.77M-240.58M-212.28M-322.54M-405.18M-246.90M-372.54M-110.18M-243.29M-168.54M-398.35M-412.94M-298.00M-237.69M-228.90M-305.11M-212.21M-
Financing Cash Flow24.00M43.79M-98.28M422.62M-12.44M16.32M163.42M-157.98M-209.49M-90.75M48.87M77.66M46.49M128.16M477.53M73.13M-3.67M-163.55M-75.02M-25.23M44.53M-46.23M35.04M-139.73M-130.66M-196.11M184.78M-
Capital Expenditure60.97M66.54M47.09M73.79M146.08M184.05M141.20M83.45M91.19M87.74M162.33M244.56M217.87M337.57M386.46M343.04M260.17M169.09M227.07M261.11M385.99M366.51M280.19M249.23M244.76M325.13M212.42M115.60M
Free Cash Flow10.18M-15.90M120.45M-87.50M-103.36M-52.73M-82.08M95.41M42.11M32.85M-162.22M100.24M-44.87M-240.49M-348.65M-250.40M86.17M179.55M212.28M128.86M-41.38M-18.24M140.00M9.89M513.48M-59.85M155.19M418.13M
Dividends Paid23.76M23.19M28.36M37.76M34.33M27.81M24.82M22.53M32.99M19.60M31.43M32.32M32.79M49.37M83.84M70.23M83.81M85.96M70.11M54.41M89.79M62.19M74.62M94.11M100.44M175.90M225.85M209.78M
FCF to OCF14.30%-31.40%71.89%637.99%-241.99%-40.15%-138.82%53.34%31.59%27.24%-156768.57%29.07%-25.93%-247.71%-921.91%-270.30%24.88%51.50%48.32%33.04%-12.01%-5.24%33.32%3.82%67.72%-22.56%42.22%78.34%
Dividend Paid to FCF233.42%-145.82%23.54%-43.15%-33.21%-52.74%-30.24%23.62%78.33%59.67%-19.37%32.24%-73.07%-20.53%-24.05%-28.05%97.26%47.88%33.03%42.23%-217.01%-340.92%53.30%951.53%19.56%-293.89%145.53%50.17%

Earnings

Report DateMay 28, 2003Aug 1, 2003Dec 3, 2003Mar 19, 2004May 28, 2008Aug 1, 2008Dec 3, 2008Mar 20, 2009Jun 3, 2009Jul 31, 2009Dec 2, 2009Mar 19, 2010Jun 2, 2010Jul 30, 2010Dec 1, 2010Mar 18, 2011Jun 1, 2011Aug 5, 2011Nov 30, 2011Mar 23, 2012May 30, 2012Aug 3, 2012Nov 28, 2012Mar 22, 2013Apr 29, 2013Jul 30, 2013Oct 30, 2013Mar 21, 2014Apr 28, 2014Aug 1, 2014Oct 27, 2014Mar 30, 2015Apr 24, 2015Jul 30, 2015Oct 25, 2015Mar 30, 2016Apr 29, 2016Aug 29, 2016Oct 26, 2016Mar 14, 2017Apr 18, 2017Aug 13, 2017Oct 30, 2017Mar 25, 2018Apr 20, 2018Aug 16, 2018Oct 23, 2018Jan 14, 2019Apr 24, 2019Aug 19, 2019Oct 28, 2019Mar 23, 2020Apr 22, 2020Aug 24, 2020Oct 23, 2020Mar 31, 2021Apr 10, 2021Aug 26, 2021Oct 22, 2021Mar 29, 2022Apr 11, 2022Aug 30, 2022Oct 25, 2022Mar 24, 2023Apr 20, 2023Aug 24, 2023Oct 27, 2023Mar 28, 2024Apr 25, 2024Aug 22, 2024Oct 29, 2024Dec 31, 2024Apr 28, 2025Aug 26, 2025Oct 27, 2025Mar 27, 2026Apr 29, 2026Aug 25, 2026
EPS Estimate-----------------------------------------------------------------------0.160.270.170.110.250.180.17
EPS Actual0.040.030.01-0.010.020.010.010.010.030.040.040.070.050.050.050.010.050.050.03-0.010.020.030.00-0.01-0.010.020.050.000.010.060.010.000.020.020.060.040.030.040.070.060.090.090.110.060.110.090.110.090.120.120.150.100.140.140.120.130.160.160.140.100.170.130.150.180.220.170.180.150.210.170.120.180.150.160.030.040.120.10
Surprise-----------------------------------------------------------------------15.00%-44.44%-5.88%-70.00%-84.00%-35.94%-41.18%
Timing-----------------------------Pre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-market------------Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-Pre-market-Pre-market

Key Statistics & Ratios

Market Cap10.17B
Enterprise Value8.15B
Trailing P/E47.10
Forward P/E28.90
PEG Ratio0.00
Price / Sales1.20
Price / Book1.92
EPS0.31
Book Value7.57
Revenue (TTM)8.47B
Gross Profit (TTM)1.51B
EBITDA857.05M
Profit Margin2.54%
Operating Margin2.78%
Return on Equity4.10%
Return on Assets1.89%
Shares Outstanding501.68M
Shares Float463.71M
Beta-0.03
Dividend Yield1.07%
Dividend Rate0.15
Payout Ratio52.03%

Dividends

20261×
0.15Jul 31, 2026
20251×
0.25Jul 18, 2025
20242×
0.03Sep 27, 20240.25Jul 30, 2024
20231×
0.20Jul 26, 2023
20221×
0.15Aug 5, 2022
20211×
0.15Jul 30, 2021
20201×
0.12Aug 7, 2020
20191×
0.10Jul 26, 2019
20182×
0.04Jul 27, 20180.02Jan 26, 2018
20161×
0.02Aug 12, 2016
20151×
0.02Aug 19, 2015
20141×
0.02Jul 18, 2014
20131×
0.01Jun 26, 2013
20121×
0.02Aug 14, 2012
20111×
0.04Aug 19, 2011
20101×
0.04Aug 24, 2010
20091×
0.02Jul 20, 2009
20081×
0.02Aug 1, 2008
20071×
0.02Aug 13, 2007
20061×
0.04Jun 20, 2006
20041×
0.03Aug 3, 2004
20031×
0.05Jul 16, 2003

Stock Splits

  • Jul 27, 20181.3:1